Loading…
Inhousepharmacy.vu, a Vanuatu-based online pharmacy, was cited for unlawfully selling unapproved domperidone drug products to U.S. consumers via the internet in violation of sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act. Domperidone has never been approved for sale in the U.S. and poses serious safety risks including cardiac arrhythmias, cardiac arrest, and sudden death, with risks amplified by concurrent use of common medications like erythromycin. The company's website introduced these unapproved drugs into interstate commerce without FDA oversight, circumventing regulatory safeguards that ensure drug safety, effectiveness, and consistent ingredient quality. The FDA requested that the company immediately cease offering any unapproved drugs for sale to American consumers.